hoodb.com

禮來IL-23抑制劑擴適應症獲批治中重度克隆氏症;GE HealthCare攜手UCSF 創癌症、神經退化性疾病影像研究中心

|

You are leaving and open the following URL" of about " 23" news

news.google.com/rss/articles/CBMiaEFVX3lxTE4xeGE3dmRldXlIZk01Zi1uWEZmeXZtTTB3OC0zRk1JVFNWRzMtTU91U1hLV1hXQWlJZ0ZpZzc3aUhOckJsZE5jRW1hdG5tSWl6NXJYVklxeXNsTENabVdLeGUzdTV0ZzR3?oc=5


Continue Opne >

23: 禮來IL-23抑制劑擴適應症獲批治中重度克隆氏症;GE HealthCare攜手UCSF 創癌症、神經退化性疾病影像研究中心


More 23 news:



Warning: filemtime(): stat failed for aCache/aaa/gnews/DK/ 23.xml in /var/www/hoodb/function.php on line 339
1737047217-
Warning: file_put_contents(aCache/aaa/gnews/DK// 23.xml): Failed to open stream: No space left on device in /var/www/hoodb/function.php on line 348

About 23

from
1737047217-1736892642

Warning: filemtime(): stat failed for aCache/search/dk/ 23 in /var/www/hoodb/function.php on line 339
1737047217-

23, 禮來IL-23抑制劑擴適應症獲批治中重度克隆氏症;GE HealthCare攜手UCSF 創癌症、神經退化性疾病影像研究中心 2022 23

禮來IL-23抑制劑擴適應症獲批治中重度克隆氏症;GE HealthCare攜手UCSF 創癌症、神經退化性疾病影像研究中心

Choose Your Country or Region


Back to Top



禮來IL-23抑制劑擴適應症獲批治中重度克隆氏症;GE HealthCare攜手UCSF 創癌症、神經退化性疾病影像研究中心

Copyright © 2020-2021 hoodb.com. All Rights Reserved.